Oxbridge Re (OXBR) to Release Earnings on Monday

Oxbridge Re (NASDAQ:OXBR) is anticipated to announce its Q4 2025 results after the market closes on Monday, March 30th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $0.70 million for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Monday, March 30, 2026 at 4:30 PM ET.

Oxbridge Re Trading Down 0.2%

NASDAQ:OXBR opened at $0.89 on Friday. The company’s 50-day moving average price is $1.04 and its 200-day moving average price is $1.39. Oxbridge Re has a twelve month low of $0.76 and a twelve month high of $2.86. The company has a market cap of $6.82 million, a P/E ratio of -2.61 and a beta of 2.27.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Oxbridge Re in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $5.00.

Institutional Trading of Oxbridge Re

A hedge fund recently raised its stake in Oxbridge Re stock. J.W. Cole Advisors Inc. increased its holdings in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) by 106.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,000 shares of the insurance provider’s stock after purchasing an additional 35,000 shares during the quarter. J.W. Cole Advisors Inc. owned 0.89% of Oxbridge Re worth $90,000 as of its most recent filing with the SEC. 5.64% of the stock is currently owned by institutional investors and hedge funds.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.